Pain Therapeutics, Inc. (NASDAQ: PTIE) is having an incredibly rough start to the trading session this morning, coming off of the gains the stock saw in the market yesterday. Nonetheless, if you’re looking for a dip to buy, this is likely it. Today, we’ll talk about: Why the stock climbed yesterday and is falling today; … Read more
Pain Therapeutics, Inc. (NASDAQ: PTIE) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The comapny recently announced an invetor call, promising to provide a strategic update. It seems as though this is what is exciting investors this morning. Today, we’ll talk about: The investor call; what we’re … Read more
After flying in the market yesterday due to a grant announcement, Pain Therapeutics, Inc. (NASDAQ: PTIE) is seeing dramatic declines in the market this morning. The declines are ultimately the result of news surrounding a dilutive offering. Of course, investors never respond well to dilution. Today, we’ll talk about: The offering; what we’re seeing from PTIE … Read more
Pain Therapeutics, Inc. (NASDAQ: PTIE) is rocketing toward the top early on in the trading session this morning, and fro good reason. The company announced that it has been awarded a grant surrounding its Alzheimer’s disease treatment that is under development. Of course, the news excited investors, sending the stock on a tear for the … Read more
Pain Therapeutics, Inc. (NASDAQ: PTIE) is having an overwhelmingly rough start to the trading session in the pre-market hours this morning, and for good reason. The company announced that it has received a Complete Response Letter (CRL) from the United States Food and Drug Administration (FDA), surrounding its New Drug Application (NDA) for REMOXY. Unforutnatley, … Read more
Pain Therapeutics, Inc. (NASDAQ: PTIE) is tanking in the market this morning, and for good reason. The company announced FDA news surrounding an Advisory Committee vote. Unfortunately, the vote did not go in the company’s favor. As you can imagine, the news upset investors, leading to a massive drop in the value of the stock. … Read more
Pain Therapeutics, Inc. (NASDAQ: PTIE) is halted early on in the trading session this morning. The halt is a T1 halt, which means that the stock is not trading, as material news is set to be released. Chances are that the release will happen at some point today. While NASDAQ does not tell you what … Read more
Pain Therapeutics, Inc. (NASDAQ: PTIE) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced overwhelmingly positive data surrounding a key clinical candidate, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about the results, what we’re seeing from … Read more
Pain Therapeutics, Inc. (NASDAQ: PTIE) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced the successful completion of a Phase 1 clinical trial, leading to excitement among investors who are sending the stock on an explosive ride upward. Of course, our partners at Trade Ideas … Read more
Pain Therapeutics, Inc. (NASDAQ: PTIE) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has been awarded a key grant which will help to fund further development of a lead pipeline drug. Of course, this led to excitement among investors, sending the stock … Read more